Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0GM9E
|
||||
Former ID |
DIB014696
|
||||
Drug Name |
RQ-00310941
|
||||
Synonyms |
RQ-00202065; 5-HT 2b antagonists (oral, IBS), RaQualia; 5-HT 2b antagonists (oral, irritable bowel syndrome), RaQualia
|
||||
Indication | Irritable bowel syndrome [ICD9: 564.1, 787.91; ICD10:A09, K58, K59.1] | Investigative | [543921] | ||
Company |
RaQualia Pharma Inc
|
||||
Canonical SMILES |
n1(nc(cc1c1cnc2c(c1)cccc2)C(=O)NCCN1CCOCC1)C
|
||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 2B receptor | Target Info | Antagonist | [543921] | |
PANTHER Pathway | 5HT2 type receptor mediated signaling pathway | ||||
References |
If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.